J Timothy Greenamyre

J Timothy Greenamyre

University of Pittsburgh - Pittsburgh / United States
Others
AD Scientific Index ID: 1778851
person_outline J Timothy Greenamyre's MOST POPULAR ARTICLES
1-) Chronic systemic pesticide exposure reproduces features of Parkinson\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseR Betarbet, TB Sherer, G MacKenzie, M Garcia-Osuna, AV Panov, ...Nature neuroscience 3 (12), 1301-1306, 200043152000
2-) Unified Huntington\'s disease rating scale: reliability and consistencyK Kieburtz, JB Penney, P Como, N Ranen, I Shoulson, A Feigin, ...Movement disorders 11 (2), 136-142, 199620431996
3-) Early mitochondrial calcium defects in Huntington\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s disease are a direct effect of polyglutaminesAV Panov, CA Gutekunst, BR Leavitt, MR Hayden, JR Burke, ...Nature neuroscience 5 (8), 731-736, 200212082002
4-) Mechanism of toxicity in rotenone models of Parkinson\'s diseaseTB Sherer, R Betarbet, CM Testa, BB Seo, JR Richardson, JH Kim, ...Journal of Neuroscience 23 (34), 10756-10764, 200312502003
5-) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregationTB Sherer, JH Kim, R Betarbet, JT GreenamyreExperimental neurology 179 (1), 9-16, 20039902003